4.6 Article

A Spectral Demixing Model for Triplex In Vivo Imaging of Optical Coherence Tomography Contrast Agents

Journal

ACS PHOTONICS
Volume 7, Issue 4, Pages 893-900

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsphotonics.9b01819

Keywords

OCT; contrast agents; spectral imaging; multiplexing; angiography

Funding

  1. United States Air Force [FA9550-15-1-0007]
  2. National Institutes of Health [NIH DP50D012179]
  3. National Science Foundation [NSF 1438340]
  4. Damon Runyon Cancer Research Foundation (DFS) [06-13]
  5. Claire Giannini Fund
  6. Susan G. Komen Breast Cancer Foundation [SAB15-00003]
  7. Mary Kay Foundation [017-14]
  8. Skippy Frank Foundation
  9. Donald E. and Delia B. Baxter Foundation
  10. Center for Cancer Nanotechnology Excellence and Translation (CCNE-T) [NIH-NCI U54CA151459]
  11. Stanford Bio-X Interdisciplinary Initiative Seed Grant [IIP6-43]
  12. Pew Charitable Trusts
  13. Alexander and Margaret Stewart Trust

Ask authors/readers for more resources

The ability to detect multiple contrast agents simultaneously would greatly enhance optical coherence tomography (OCT) images, providing nuanced biological context to physiological structures. However, previous OCT contrast agent work has been limited to scenarios where only a single contrast agent could be robustly detected within each voxel. We present a novel spectroscopic technique for demixing the spectral signal from multiple OCT contrast agents within a single voxel. We validate our technique in vitro and also demonstrate in vivo imaging of three spectrally distinct gold nanobipyramids, trafficking within the lymphatic system of a live mouse.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available